Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric
Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth: A Randomized Clinical Trial
Sponsor: Virginia Commonwealth University
Terminated
Drug is no longer being manufactured
Other terminated trials from Virginia Commonwealth University
Other Apical Periodontitis trials with similar outcome
This PHASE2 trial investigates Apical Periodontitis and Caries,Dental and is currently terminated or withdrawn. Virginia Commonwealth University leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 6 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Nov 2019 — Dec 2020 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .